MiR-181a-5p has previously been found to be a target of LncRNA MALAT1, whose interference decreased the expression of miR-181a-5p and inhibited the proliferation and adhesion of myeloma cells [58]. The gene discussed is MALAT1; the disease is plasma cell myeloma.